TRIO
Business Services · Canada · 201-500 Employees
View Company Info for Free
Overview
Headquarters
9925 109 St NW Suite 1100, Edmonton, Alb...Phone Number
(780) 702-0200Website
www.trioncology.orgRevenue
$7.4 MillionIndustry
About TRIO
TRIO is a full-service clinical research organization (CRO) specializing in oncology, leveraging a global network of investigators and experts to accelerate drug development. The organization focuses on conducting cancer clinical trials, ensuring timely enrollment and high-quality execution, with a proven track record of success in phase III trials. TRIO partners with sponsors to enhance the drug development process and improve patient outcomes, supported by a robust network of over 500 investigational sites across more than 20 countries. With a commitment to advancing cancer research, TRIO fosters long-term partnerships built on trust and success.Explore more
TRIO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to TRIO
Compare insights from companies similar to TRIO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
TRIO Tech Stack
A closer look at the technologies used by TRIO
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding TRIO
Sign Up For FreeTo access detailed company insights
TRIO is a full-service clinical research organization (CRO) specializing in oncology, leveraging a global network of investigators and experts to accelerate drug development. The organization focuses on conducting cancer clinical trials, ensuring timely enrollment and high-quality execution, with a proven track record of success in phase III trials... Read More
